The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

Pharmacy benefit managers started popping up in the late 1960s as providers of claims processing and administrative services ...

Weight-loss medications surged in popularity this year. A survey from Kaiser Family Foundation found one in eight adults have ...

Adorned in a Santa suit in a photo posted to X, the Tesla founder indicates he’s taking one of the widely popular weight-loss ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Plenty of people want to lose weight in 2025, but here's why many may actually get there thanks to GLP-1 drugs.

No one has ever known so much about healthy eating and been less successful at following her own advice.

Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...

Elon Musk is accomplishing some end-of-the-year goals. The tech billionaire has shared a photo showing off his impressive ...

Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...

Citi analysts forecast 19% earnings growth for the healthcare sector in 2025 amid improving fundamentals and a boom in weight ...